{"abstract": "Carl Icahn has never shied away from a proxy fight, but the activist investor has turned especially feisty in his battle with the drug maker Amylin Pharmaceuticals.", "web_url": "https://dealbook.nytimes.com/2009/04/15/icahn-wields-his-poison-pen-again/", "snippet": "", "lead_paragraph": "Carl Icahn has never shied away from a proxy fight, but the activist investor has turned especially feisty in his battle with the drug maker Amylin Pharmaceuticals.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Icahn Wields His Poison Pen Again", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-04-15T16:59:49+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e8516d2b-5fb0-54cb-a4c2-15bb79e11037", "word_count": 370, "uri": "nyt://article/e8516d2b-5fb0-54cb-a4c2-15bb79e11037"}